NewsEpisealer® clinical results accepted for presentation at the German Knee Society Congress

Episurf Medical (NASDAQ: EPIS B) today announces further progress on its important strategy of generating clinical results from the use of the Episealer® knee implant.

The scientific abstract “Clinical results of an individualized mini-metal implant for focal cartilage lesions in the knee” by Johannes Holz, Tim Spalding, Karl Eriksson, Tobias Jung, Peter Verdonk and Clemens Kösters has been accepted for presentation at the 7th Annual Congress of the Deutschen Kniegesellschaft (DKG, the German Knee Society). The congress will take place in Munich on November 23-24, 2018. The abstract covers interim results from a European multicenter study on the Episealer® knee implant and will be presented by Dr. med. Johannes Holz from OrtoCentrum, Hamburg.

“We are happy that the clinical results from the use of Episealer® knee implants will be presented at this focused meeting. This adds to the genuine interest in our technology that we are experiencing now”, says Pål Ryfors, CEO of Episurf Medical.

For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69